Charles Schwab Investment Management Inc Blueprint Medicines Corp Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 604,397 shares of BPMC stock, worth $62.9 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
604,397
Previous 597,232
1.2%
Holding current value
$62.9 Million
Previous $55.2 Million
4.54%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding BPMC
# of Institutions
362Shares Held
61.8MCall Options Held
2.24MPut Options Held
1.15M-
Vanguard Group Inc Valley Forge, PA6.77MShares$705 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$691 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$560 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$412 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$288 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.21B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...